Leash Bio
A biotechnology company focused on AI-driven drug discovery. Its core direction is using DNA-encoded library (DEL) data to train AI chemists, accelerating compound screening and model iteration through a Lab-in-the-Loop closed loop.
Timeline (last 90 days)
Leash Bio uses a Lab-in-the-Loop closed-loop approach, combining DEL experiments with iterative AI model updates to run the cycle of experimental design and data analysis at computational speed.
Leash Bio uses DEL data for model evaluation, which can identify models that score high on standard benchmarks but have poor generalization ability.
Leash Bio repositions DEL as AI training infrastructure, producing reasoning-trajectory data with experimentally validated labels, rather than as a traditional one-off screening tool.
All Facts (3)
Leash Bio uses a Lab-in-the-Loop closed-loop approach, combining DEL experiments with iterative AI model updates to run the cycle of experimental design and data analysis at computational speed.
50%UnverifiedLeash Bio uses DEL data for model evaluation, which can identify models that score high on standard benchmarks but have poor generalization ability.
50%UnverifiedLeash Bio repositions DEL as AI training infrastructure, producing reasoning-trajectory data with experimentally validated labels, rather than as a traditional one-off screening tool.
50%